Correspondence on 'Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences' by Ruscitti et al
- PMID: 32907800
- DOI: 10.1136/annrheumdis-2020-218876
Correspondence on 'Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences' by Ruscitti et al
Keywords: chemokines; cytokines; immune system diseases; inflammation.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Response to: 'Correspondence on 'Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences' by Ruscitti et al' by Chen et al.Ann Rheum Dis. 2022 Nov;81(11):e221. doi: 10.1136/annrheumdis-2020-218909. Epub 2020 Sep 9. Ann Rheum Dis. 2022. PMID: 32907802 No abstract available.
Comment on
-
Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences.Ann Rheum Dis. 2020 Sep;79(9):1152-1155. doi: 10.1136/annrheumdis-2020-218048. Epub 2020 Jul 21. Ann Rheum Dis. 2020. PMID: 32719039 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
